Gelteq Limited (GELS) vs PainReform Ltd. (PRFX)

Gelteq Limited and PainReform Ltd. are both Drug Manufacturers Specialty & Generic companies. Gelteq Limited is the larger, with a market value of $5.9M against $3.0M — 2.0× the size. Across the 5 metrics below, PainReform Ltd. leads on 3 and Gelteq Limited on 2.

Valuation

Metric GELS PRFX Drug Manufacturers Specialty & Generic median
P/E — n/m 20.14
P/S — n/m 2.25
P/B n/m 0.00 1.90
Price to free cash flow n/m n/m 16.54
EV/EBITDA n/m 0.99 12.29
EV/Sales n/m n/m 2.56
Earnings yield — (61,696.04%) (2.99%)
Free cash flow yield 0.00% (80,633.63%) 0.00%

Profitability

Metric GELS PRFX Drug Manufacturers Specialty & Generic median
Gross margin — 0.00% 53.94%
Operating margin — 0.00% 0.00%
Net margin — 0.00% 0.00%
Free cash flow margin 0.00% 0.00% 0.00%
Return on equity 0.00% 0.00% (0.40%)
Return on assets 0.00% 0.00% (3.32%)
Return on invested capital 0.00% 0.00% 0.00%

Growth

Metric GELS PRFX Drug Manufacturers Specialty & Generic median
Revenue growth (TTM) — — 10.01%
EPS growth (last fiscal year) (62.07%) 92.92% —
Revenue growth, 5-year CAGR — — 6.74%
Net income growth, 5-year CAGR — 0.00% 0.00%

Health

Metric GELS PRFX Drug Manufacturers Specialty & Generic median
Debt to equity 0.36 0.00 0.05
Current ratio 0.09 5.07 2.31
Net debt to EBITDA (0.91) 0.96 0.85

Dividend

Metric GELS PRFX Drug Manufacturers Specialty & Generic median
Dividend yield — — 1.70%
Payout ratio — 0.00 0.00

Size

Metric GELS PRFX Drug Manufacturers Specialty & Generic median
Market cap 5.89m 2.95m 337.35m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack